Senti Biosciences, Inc.SNTINASDAQ
Loading
Year-over-year research & development expense growth
Percentile
P63
Within normal range
vs 2Y Ago
0.1x
Contraction
Streak
2 qtr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| Q3 2025 | 4.94% |
| Q2 2025 | 5.65% |
| Q1 2025 | 23.09% |
| Q4 2024 | -12.88% |
| Q3 2024 | -2.71% |
| Q2 2024 | 4.43% |
| Q1 2024 | -6.61% |
| Q4 2023 | 0.33% |
| Q3 2023 | 48.50% |
| Q2 2023 | -9.62% |
| Q1 2023 | -26.07% |
| Q4 2022 | 40.56% |
| Q3 2022 | -29.50% |
| Q2 2022 | 40.25% |
| Q1 2022 | 22.66% |
| Q4 2021 | -0.65% |
| Q3 2021 | 26.46% |
| Q2 2021 | 0.00% |
| Q1 2021 | -100.00% |
| Q4 2020 | 0.00% |